Zkusit zdarma
Olema Pharmaceuticals, Inc.

Olema Pharmaceuticals, Inc.

OLMA
Cena:
$ 13.68
-0.38 (-2.70%)
Valuace
70
Růst
0
Zdraví
75
Souhrn Finanční data Pro investory Předpovědi Zprávy Dividendy Zisky Návštěvnost webu Akcionáři
Souhrn
Finanční data
Pro investory
Předpovědi
Zprávy
Dividendy
Zisky
Návštěvnost webu
Akcionáři

Zprávy

Zahraniční články
Tiskové zprávy
Dokumenty ke stáhnutí
Olema Oncology Announces Encouraging Initial Clinical Data from the Phase 1 Study of OP-3136, a KAT6 Inhibitor, at 2026 ASCO Annual Meeting

Olema Oncology Announces Encouraging Initial Clinical Data from the Phase 1 Study of OP-3136, a KAT6 Inhibitor, at 2026 ASCO Annual Meeting

17:00 21-05-2026

OP-3136 monotherapy was well-tolerated with no dose-limiting toxicities observed and no discontinuat...

Olema Oncology to Participate in Upcoming Investor Conferences

Olema Oncology to Participate in Upcoming Investor Conferences

16:30 19-05-2026

SAN FRANCISCO, May 19, 2026 (GLOBE NEWSWIRE) -- Olema Pharmaceuticals, Inc. (“Olema” or “Olema...

Olema Oncology Appoints Prakash Raman, Ph.D., to Board of Directors

Olema Oncology Appoints Prakash Raman, Ph.D., to Board of Directors

16:01 29-04-2026

SAN FRANCISCO, April 29, 2026 (GLOBE NEWSWIRE) -- Olema Pharmaceuticals, Inc. (“Olema” or “Ole...

Olema Oncology to Present Initial Clinical Data for OP-3136 at the 2026 ASCO Annual Meeting

Olema Oncology to Present Initial Clinical Data for OP-3136 at the 2026 ASCO Annual Meeting

16:01 21-04-2026

SAN FRANCISCO, April 21, 2026 (GLOBE NEWSWIRE) -- Olema Pharmaceuticals, Inc. (“Olema” or “Ole...

Analyzing Olema Pharmaceuticals (NASDAQ:OLMA) and Ligand Pharmaceuticals (NASDAQ:LGND)

Analyzing Olema Pharmaceuticals (NASDAQ:OLMA) and Ligand Pharmaceuticals (NASDAQ:LGND)

1:44 13-04-2026

Olema Pharmaceuticals (NASDAQ: OLMA - Get Free Report) and Ligand Pharmaceuticals (NASDAQ: LGND - Ge...

SG Americas Securities LLC Purchases Shares of 69,382 Olema Pharmaceuticals, Inc. $OLMA

SG Americas Securities LLC Purchases Shares of 69,382 Olema Pharmaceuticals, Inc. $OLMA

5:03 06-04-2026

SG Americas Securities LLC bought a new stake in shares of Olema Pharmaceuticals, Inc. (NASDAQ: OLMA...

Olema Stock Up 242%, but Does a $122 Million Position Suggest More Upside Potential?

Olema Stock Up 242%, but Does a $122 Million Position Suggest More Upside Potential?

12:08 22-03-2026

Paradigm Biocapital Advisor increased its stake in Olema Pharmaceuticals by 750,000 shares in Q4 202...

Biotech Stock Up Nearly 300% Draws $68.7 Million Bet as Breast Cancer Drug Targets 2027 Launch

Biotech Stock Up Nearly 300% Draws $68.7 Million Bet as Breast Cancer Drug Targets 2027 Launch

18:42 16-03-2026

Cormorant Asset Management established a new stake in Olema Pharmaceuticals, purchasing 2,750,000 sh...

Olema Oncology Reports Fourth Quarter and Full Year 2025 Financial and Operating Results

Olema Oncology Reports Fourth Quarter and Full Year 2025 Financial and Operating Results

7:00 16-03-2026

On-track to report top-line data in the fall of 2026 from the pivotal Phase 3 OPERA-01 trial of pala...

Olema Pharmaceuticals, Inc. Investigated on Behalf of Investors - Contact the DJS Law Group to Discuss Your Rights – OLMA

Olema Pharmaceuticals, Inc. Investigated on Behalf of Investors - Contact the DJS Law Group to Discuss Your Rights – OLMA

13:57 09-03-2026

LOS ANGELES--(BUSINESS WIRE)--Olema Pharmaceuticals, Inc. Investigated on Behalf of Investors - Cont...

Why Is Olema Pharmaceuticals Stock Dropping On Monday?

Why Is Olema Pharmaceuticals Stock Dropping On Monday?

12:22 09-03-2026

Olema Pharmaceuticals Inc. (NASDAQ: OLMA) stock is trading lower on Monday, in reaction to data from...

Olema Pharmaceuticals, Inc. (OLMA) Presents at Citi's 2026 Virtual Oncology Leadership Summit Transcript

Olema Pharmaceuticals, Inc. (OLMA) Presents at Citi's 2026 Virtual Oncology Leadership Summit Transcript

12:04 23-02-2026

Olema Pharmaceuticals, Inc. (OLMA) Presents at Citi's 2026 Virtual Oncology Leadership Summit Transc...

Olema Pharmaceuticals CEO Teases Fall OPERA-01 Readout, Q2 KAT6 Data and CFO/COO Exit

Olema Pharmaceuticals CEO Teases Fall OPERA-01 Readout, Q2 KAT6 Data and CFO/COO Exit

1:02 16-02-2026

Olema Pharmaceuticals (NASDAQ: OLMA) is focused on developing endocrine therapies aimed at improving...

Olema Pharmaceuticals, Inc. (OLMA) Presents at Guggenheim Securities Emerging Outlook: Biotech Summit 2026 Transcript

Olema Pharmaceuticals, Inc. (OLMA) Presents at Guggenheim Securities Emerging Outlook: Biotech Summit 2026 Transcript

16:47 13-02-2026

Olema Pharmaceuticals, Inc. (OLMA) Presents at Guggenheim Securities Emerging Outlook: Biotech Summi...

Olema Oncology to Participate in Upcoming Investor Conferences

Olema Oncology to Participate in Upcoming Investor Conferences

16:30 04-02-2026

SAN FRANCISCO, Feb. 04, 2026 (GLOBE NEWSWIRE) -- Olema Pharmaceuticals, Inc. (“Olema”, or “Ol...

Olema Oncology Announces Departure of Chief Operating and Financial Officer

Olema Oncology Announces Departure of Chief Operating and Financial Officer

16:01 30-01-2026

SAN FRANCISCO, Jan. 30, 2026 (GLOBE NEWSWIRE) -- Olema Pharmaceuticals, Inc. (“Olema”, or “Ol...

Campbell & CO Investment Adviser LLC Buys New Shares in Olema Pharmaceuticals, Inc. $OLMA

Campbell & CO Investment Adviser LLC Buys New Shares in Olema Pharmaceuticals, Inc. $OLMA

3:14 24-01-2026

Campbell and CO Investment Adviser LLC bought a new position in shares of Olema Pharmaceuticals, Inc...

Olema Pharmaceuticals (NASDAQ:OLMA) Director Cyrus Harmon Sells 3,489 Shares

Olema Pharmaceuticals (NASDAQ:OLMA) Director Cyrus Harmon Sells 3,489 Shares

6:21 20-01-2026

Olema Pharmaceuticals, Inc. (NASDAQ: OLMA - Get Free Report) Director Cyrus Harmon sold 3,489 shares...

Olema Pharmaceuticals, Inc. (OLMA) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Olema Pharmaceuticals, Inc. (OLMA) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

12:05 15-01-2026

Olema Pharmaceuticals, Inc. (OLMA) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcr...

Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) Receives Consensus Rating of “Moderate Buy” from Brokerages

Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) Receives Consensus Rating of “Moderate Buy” from Brokerages

1:28 12-01-2026

Shares of Olema Pharmaceuticals, Inc. (NASDAQ: OLMA - Get Free Report) have been assigned an average...

close

OLEMA ONCOLOGY TO PARTICIPATE IN UPCOMING INVESTOR CONFERENCES

04-02-2026
SAN FRANCISCO, FEB. 04, 2026 (GLOBE NEWSWIRE) -- OLEMA PHARMACEUTICALS, INC. (“OLEMA”, OR “OL...
Více zde

OLEMA ONCOLOGY REPORTS INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(C)(4)

03-02-2026
SAN FRANCISCO, FEB. 03, 2026 (GLOBE NEWSWIRE) -- OLEMA PHARMACEUTICALS, INC. (“OLEMA” OR “OLEM...
Více zde

OLEMA ONCOLOGY ANNOUNCES DEPARTURE OF CHIEF OPERATING AND FINANCIAL OFFICER

30-01-2026
SAN FRANCISCO, JAN. 30, 2026 (GLOBE NEWSWIRE) -- OLEMA PHARMACEUTICALS, INC. (“OLEMA”, OR “OL...
Více zde

OLEMA ONCOLOGY REPORTS INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(C)(4)

05-01-2026
SAN FRANCISCO, JAN. 05, 2026 (GLOBE NEWSWIRE) -- OLEMA PHARMACEUTICALS, INC. (“OLEMA” OR “OLEM...
Více zde

OLEMA ONCOLOGY TO PRESENT AT 44TH ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE

05-01-2026
SAN FRANCISCO, JAN. 05, 2026 (GLOBE NEWSWIRE) -- OLEMA PHARMACEUTICALS, INC. (“OLEMA” OR “OLEM...
Více zde

OLEMA ONCOLOGY TO PARTICIPATE IN 8TH ANNUAL EVERCORE HEALTHCARE CONFERENCE

21-11-2025
SAN FRANCISCO, NOV. 21, 2025 (GLOBE NEWSWIRE) -- OLEMA PHARMACEUTICALS, INC. (“OLEMA”, OR “OL...
Více zde

OLEMA ONCOLOGY ANNOUNCES CLOSING OF $218.5 MILLION PUBLIC OFFERING OF COMMON STOCK AND FULL EXERCISE OF UNDERWRITERS' OPTION TO PURCHASE ADDITIONAL SHARES

20-11-2025
OLEMA ONCOLOGY ANNOUNCES CLOSING OF $218.5 MILLION PUBLIC OFFERING OF COMMON STOCK AND FULL EXERCISE...
Více zde

OLEMA ONCOLOGY ANNOUNCES PROPOSED PUBLIC OFFERING OF COMMON STOCK AND PRE-FUNDED WARRANTS

18-11-2025
SAN FRANCISCO, NOV. 18, 2025 (GLOBE NEWSWIRE) -- OLEMA PHARMACEUTICALS, INC. (“OLEMA” OR “OLEM...
Více zde

OLEMA ONCOLOGY REPORTS THIRD QUARTER 2025 FINANCIAL AND OPERATING RESULTS

10-11-2025
ANNOUNCED NEW CLINICAL TRIAL AGREEMENT WITH PFIZER TO EVALUATE PALAZESTRANT IN COMBINATION WITH ATIR...
Více zde

OLEMA ONCOLOGY REPORTS INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(C)(4)

04-11-2025
SAN FRANCISCO, NOV. 04, 2025 (GLOBE NEWSWIRE) -- OLEMA PHARMACEUTICALS, INC. (“OLEMA” OR “OLEM...
Více zde

OLEMA ONCOLOGY TO PARTICIPATE IN UPCOMING INVESTOR CONFERENCES

03-11-2025
SAN FRANCISCO, NOV. 03, 2025 (GLOBE NEWSWIRE) -- OLEMA PHARMACEUTICALS, INC. (“OLEMA”, OR “OL...
Více zde

OLEMA ONCOLOGY TO PRESENT TRIAL-IN-PROGRESS POSTER FOR PHASE 3 OPERA-02 TRIAL OF PALAZESTRANT PLUS RIBOCICLIB AT SABCS 2025

30-10-2025
SAN FRANCISCO, OCT. 30, 2025 (GLOBE NEWSWIRE) -- OLEMA PHARMACEUTICALS, INC. (“OLEMA” OR “OLE...
Více zde

OLEMA ONCOLOGY ANNOUNCES NEW DATA FROM THE PHASE 1B/2 TRIAL OF PALAZESTRANT PLUS RIBOCICLIB IN ER+/HER2- METASTATIC BREAST CANCER AT ESMO 2025

18-10-2025
PALAZESTRANT IN COMBINATION WITH RIBOCICLIB DEMONSTRATED ENCOURAGING ACTIVITY ACROSS ALL DOSE COHORT...
Více zde

OLEMA ONCOLOGY REPORTS INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(C)(4)

02-10-2025
SAN FRANCISCO, OCT. 02, 2025 (GLOBE NEWSWIRE) -- OLEMA PHARMACEUTICALS, INC. (“OLEMA” OR “OLEM...
Více zde

OLEMA ONCOLOGY REPORTS INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(C)(4)

03-09-2025
SAN FRANCISCO, SEPT. 03, 2025 (GLOBE NEWSWIRE) -- OLEMA PHARMACEUTICALS, INC. (“OLEMA” OR “OLE...
Více zde

OLEMA ONCOLOGY ANNOUNCES NEW CLINICAL TRIAL AGREEMENT WITH PFIZER TO COMBINE PALAZESTRANT WITH ATIRMOCICLIB IN ER+/HER2- METASTATIC BREAST CANCER

02-09-2025
STUDY TO EXPLORE THE PALAZESTRANT-ATIRMOCICLIB COMBINATION IN APPROXIMATELY 35 PATIENTS WITH INITIAT...
Více zde

OLEMA ONCOLOGY TO PARTICIPATE IN UPCOMING INVESTOR CONFERENCES

20-08-2025
SAN FRANCISCO, AUG. 20, 2025 (GLOBE NEWSWIRE) -- OLEMA PHARMACEUTICALS, INC. (“OLEMA”, OR “OL...
Více zde

OLEMA ONCOLOGY REPORTS SECOND QUARTER 2025 FINANCIAL AND OPERATING RESULTS

11-08-2025
SAN FRANCISCO, AUG. 11, 2025 (GLOBE NEWSWIRE) -- OLEMA PHARMACEUTICALS, INC. (“OLEMA” OR “OLEM...
Více zde

OLEMA ONCOLOGY REPORTS INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(C)(4)

04-08-2025
SAN FRANCISCO, AUG. 04, 2025 (GLOBE NEWSWIRE) -- OLEMA PHARMACEUTICALS, INC. (“OLEMA” OR “OLEM...
Více zde

OLEMA ONCOLOGY REPORTS INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(C)(4)

02-07-2025
SAN FRANCISCO, JULY 02, 2025 (GLOBE NEWSWIRE) -- OLEMA PHARMACEUTICALS, INC. (“OLEMA” OR “OLEM...
Více zde

OLEMA ONCOLOGY REPORTS INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(C)(4)

03-06-2025
SAN FRANCISCO, JUNE 03, 2025 (GLOBE NEWSWIRE) -- OLEMA PHARMACEUTICALS, INC. (“OLEMA” OR “OLEM...
Více zde

OLEMA ONCOLOGY ANNOUNCES PALAZESTRANT DOSE SELECTION AND TRIAL-IN-PROGRESS POSTER AT ASCO 2025 ANNUAL MEETING

28-05-2025
SAN FRANCISCO, MAY 28, 2025 (GLOBE NEWSWIRE) -- OLEMA PHARMACEUTICALS, INC. (“OLEMA” OR “OLEMA...
Více zde

OLEMA ONCOLOGY TO PARTICIPATE IN UPCOMING INVESTOR CONFERENCES

21-05-2025
SAN FRANCISCO, MAY 21, 2025 (GLOBE NEWSWIRE) -- OLEMA PHARMACEUTICALS, INC. (“OLEMA” OR “OLEMA...
Více zde

OLEMA ONCOLOGY REPORTS FIRST QUARTER 2025 FINANCIAL AND OPERATING RESULTS

13-05-2025
PIVOTAL PHASE 3 OPERA-02 TRIAL OF PALAZESTRANT IN COMBINATION WITH RIBOCICLIB IN FRONTLINE METASTATI...
Více zde

OLEMA ONCOLOGY TO PARTICIPATE IN UPCOMING INVESTOR CONFERENCES

09-05-2025
SAN FRANCISCO, MAY 09, 2025 (GLOBE NEWSWIRE) -- OLEMA PHARMACEUTICALS, INC. (“OLEMA”, “OLEMA ...
Více zde

OLEMA ONCOLOGY REPORTS INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(C)(4)

02-05-2025
SAN FRANCISCO, MAY 02, 2025 (GLOBE NEWSWIRE) -- OLEMA PHARMACEUTICALS, INC. (“OLEMA” OR “OLEMA...
Více zde

OLEMA ONCOLOGY ANNOUNCES NEW PRECLINICAL DATA FOR OP-3136 DEMONSTRATING ANTI-TUMOR ACTIVITY IN MULTIPLE SOLID TUMOR MODELS AT AACR 2025

25-04-2025
SAN FRANCISCO, APRIL 25, 2025 (GLOBE NEWSWIRE) -- OLEMA PHARMACEUTICALS, INC. (“OLEMA” OR “OLE...
Více zde

OLEMA ONCOLOGY REPORTS INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(C)(4)

02-04-2025
SAN FRANCISCO, APRIL 02, 2025 (GLOBE NEWSWIRE) -- OLEMA PHARMACEUTICALS, INC. (“OLEMA” OR “OLE...
Více zde

OLEMA ONCOLOGY TO PRESENT PRECLINICAL DATA FOR OP-3136, A POTENT KAT6 INHIBITOR, DEMONSTRATING ANTI-TUMOR ACTIVITY IN MULTIPLE SOLID TUMOR MODELS AT THE 2025 AACR ANNUAL MEETING

25-03-2025
SAN FRANCISCO, MARCH 25, 2025 (GLOBE NEWSWIRE) -- OLEMA PHARMACEUTICALS, INC. (“OLEMA” OR “OLE...
Více zde

OLEMA ONCOLOGY REPORTS FOURTH QUARTER AND FULL YEAR 2024 FINANCIAL AND OPERATING RESULTS

18-03-2025
SAN FRANCISCO, MARCH 18, 2025 (GLOBE NEWSWIRE) -- OLEMA PHARMACEUTICALS, INC. (“OLEMA” OR “OLE...
Více zde

close

Datum Typ Otevřít EDGAR Stáhnout dokument
2026-01-30 00:00:008-KStáhnout
2026-01-12 00:00:008-KStáhnout
2025-11-19 00:00:008-KStáhnout
2025-11-18 00:00:008-KStáhnout
2025-11-10 00:00:008-KStáhnout
2025-11-10 00:00:0010-QStáhnout
2025-10-20 01:00:008-KStáhnout
2025-10-20 00:00:008-KStáhnout
2025-09-02 01:00:008-KStáhnout
2025-09-02 00:00:008-KStáhnout
2025-08-11 01:00:008-KStáhnout
2025-08-11 01:00:0010-QStáhnout
2025-08-11 00:00:008-KStáhnout
2025-08-11 00:00:0010-QStáhnout
2025-06-13 01:00:008-KStáhnout
2025-06-13 00:00:008-KStáhnout
2025-05-13 01:00:008-KStáhnout
2025-05-13 01:00:0010-QStáhnout
2025-05-13 00:00:008-KStáhnout
2025-05-13 00:00:0010-QStáhnout
2025-03-18 00:00:008-KStáhnout
2025-03-18 00:00:0010-KStáhnout
2025-03-17 23:00:008-KStáhnout
2025-03-17 23:00:0010-KStáhnout
2025-03-05 00:00:008-KStáhnout
2025-03-04 23:00:008-KStáhnout
2025-01-13 00:00:008-KStáhnout
2025-01-12 23:00:008-KStáhnout
2025-01-10 00:00:008-KStáhnout
2025-01-09 23:00:008-KStáhnout
2024-12-10 00:00:008-KStáhnout
2024-12-09 23:00:008-KStáhnout
2024-12-02 00:00:008-KStáhnout
2024-12-01 23:00:008-KStáhnout
2024-11-12 00:00:008-KStáhnout
2024-11-12 00:00:0010-QStáhnout
2024-11-11 23:00:008-KStáhnout
2024-11-11 23:00:0010-QStáhnout
2024-09-27 01:00:008-KStáhnout
2024-09-27 00:00:008-KStáhnout
2024-08-06 01:00:008-KStáhnout
2024-08-06 01:00:0010-QStáhnout
2024-08-06 00:00:008-KStáhnout
2024-08-06 00:00:0010-QStáhnout
2024-07-02 01:00:008-KStáhnout
2024-07-02 00:00:008-KStáhnout
2024-06-14 01:00:008-KStáhnout
2024-06-14 00:00:008-KStáhnout
2024-05-15 01:00:008-KStáhnout
2024-05-15 00:00:008-KStáhnout
2024-05-08 01:00:008-KStáhnout
2024-05-08 01:00:0010-QStáhnout
2024-05-08 00:00:008-KStáhnout
2024-05-08 00:00:0010-QStáhnout
2024-03-11 00:00:008-KStáhnout
2024-03-11 00:00:0010-KStáhnout
2024-03-10 23:00:008-KStáhnout
2024-03-10 23:00:0010-KStáhnout
2024-01-08 00:00:008-KStáhnout
2024-01-07 23:00:008-KStáhnout
2024-01-05 00:00:008-KStáhnout
2024-01-04 23:00:008-KStáhnout
2023-12-06 00:00:008-KStáhnout
2023-12-05 23:00:008-KStáhnout
2023-12-05 00:00:008-KStáhnout
2023-12-04 23:00:008-KStáhnout
2023-11-07 00:00:008-KStáhnout
2023-11-07 00:00:0010-QStáhnout
2023-11-06 23:00:008-KStáhnout
2023-11-06 23:00:0010-QStáhnout
2023-10-23 01:00:008-KStáhnout
2023-10-23 00:00:008-KStáhnout
2023-10-17 01:00:008-KStáhnout
2023-10-17 00:00:008-KStáhnout
2023-10-10 01:00:008-KStáhnout
2023-10-10 00:00:008-KStáhnout
2023-09-05 01:00:008-KStáhnout
2023-09-05 00:00:008-KStáhnout
2023-08-08 01:00:008-KStáhnout
2023-08-08 01:00:0010-QStáhnout
2023-08-08 00:00:008-KStáhnout
2023-08-08 00:00:0010-QStáhnout
2023-06-21 01:00:008-KStáhnout
2023-06-21 00:00:008-KStáhnout
2023-05-11 01:00:008-KStáhnout
2023-05-11 00:00:008-KStáhnout
2023-05-09 01:00:008-KStáhnout
2023-05-09 01:00:0010-QStáhnout
2023-05-09 00:00:008-KStáhnout
2023-05-09 00:00:0010-QStáhnout
2023-03-10 00:00:008-KStáhnout
2023-03-09 23:00:008-KStáhnout
2023-03-09 00:00:008-KStáhnout
2023-03-09 00:00:0010-KStáhnout
2023-03-08 23:00:008-KStáhnout
2023-03-08 23:00:0010-KStáhnout
2022-12-16 00:00:008-KStáhnout
2022-12-15 23:00:008-KStáhnout
2022-11-08 00:00:008-KStáhnout
2022-11-08 00:00:0010-QStáhnout
2022-11-07 23:00:008-KStáhnout
2022-11-07 23:00:0010-QStáhnout
2022-08-09 01:00:008-KStáhnout
2022-08-09 01:00:0010-QStáhnout
2022-08-09 00:00:008-KStáhnout
2022-08-09 00:00:0010-QStáhnout
2022-06-23 01:00:008-KStáhnout
2022-06-23 00:00:008-KStáhnout
2022-06-09 01:00:008-KStáhnout
2022-06-09 00:00:008-KStáhnout
2022-05-09 01:00:008-KStáhnout
2022-05-09 01:00:0010-QStáhnout
2022-05-09 00:00:008-KStáhnout
2022-05-09 00:00:0010-QStáhnout
2022-03-14 00:00:008-KStáhnout
2022-03-13 23:00:008-KStáhnout
2022-02-28 00:00:008-KStáhnout
2022-02-28 00:00:0010-KStáhnout
2022-02-27 23:00:008-KStáhnout
2022-02-27 23:00:0010-KStáhnout
2021-11-10 00:00:008-KStáhnout
2021-11-10 00:00:0010-QStáhnout
2021-11-09 23:00:008-KStáhnout
2021-11-09 23:00:0010-QStáhnout
2021-08-10 01:00:008-KStáhnout
2021-08-10 01:00:0010-QStáhnout
2021-08-10 00:00:008-KStáhnout
2021-08-10 00:00:0010-QStáhnout
2021-06-09 01:00:008-KStáhnout
2021-06-09 00:00:008-KStáhnout
2021-05-11 01:00:008-KStáhnout
2021-05-11 01:00:0010-QStáhnout
2021-05-11 00:00:008-KStáhnout
2021-05-11 00:00:0010-QStáhnout
2021-04-06 01:00:008-KStáhnout
2021-04-06 00:00:008-KStáhnout
2021-03-17 00:00:008-KStáhnout
2021-03-17 00:00:0010-KStáhnout
2021-03-16 23:00:008-KStáhnout
2021-03-16 23:00:0010-KStáhnout
2020-11-23 00:00:008-KStáhnout
2020-11-22 23:00:008-KStáhnout
preloader